You searched for "glaucomatous"
Ultrasound biomicroscopy (part 2): primary angle closure
Patients with primary angle closure or primary angle closure glaucoma [PAC(G)] comprise a significant subgroup affecting around 10% of glaucoma patients amongst Caucasians. Assessment of the patient with angle closure, or narrow angles, requires gonioscopy. However, whilst identifying the presence...Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat
1 April 2017
| Annie SeeWah Tung
|
EYE - Vitreo-Retinal
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...
Report: UKEGS 2024
29 October 2024
|
UKEGS, 2024, conferences, meetings, events, industry, glaucoma, Glaucoma UK, Nishani Amerasinghe, Andrew Tatham
It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...
Innovations in ophthalmology: what can the innovations of the past teach us about tomorrow?
BUOS Prize Essay – 2nd prize winner for 2013 submissions Introduction An essay titled Innovations in Ophthalmology might choose to focus on the history; from cataract couching to femtosecond lasers, ophthalmology has had no shortage of topics worthy of discussion....The world in union
4 October 2023
| David Lockington, Baljean Dhillon (Prof)
"It’s the world in union, the world as one…” Hearing these lyrics as a sports fan means only one thing: it’s time for the Rugby World Cup! This four-yearly sporting extravaganza should hit your TV screens around the same time...
Vision loss during Eylea treatment for AMD
1 December 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
This report investigated patients who lost more than two lines of vision despite periodic injections of aflibercept and explored the factors associated with vision loss. One hundred and ninety-six eyes were included in this study over a two year period....
Atrophy and anti-VEGF
1 August 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The aim of this study was to investigate treatment factors, along with ocular and systemic factors for their association with macular atrophy (MA) incidence in eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF aflibercept or ranibizumab according to...
Treat-and-extend regimen in treatment of patients with type 3 neovascularisation
5 October 2020
| Su Young
|
EYE - Vitreo-Retinal
Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...
Lines, dots, spots and rings in ophthalmology: understanding eponyms
1 April 2015
| Tafadzwa Young-Zvandasara
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Eponymous names are familiar to all who have undergone undergraduate and postgraduate training in medicine. The ability to name a few allows one to stand out among your peers and rare, or not so rare, eponymous syndromes are a favourite...
Retinal pigment epithelium tears
1 June 2016
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this paper the authors review the current knowledge of retinal pigment epithelium (RPE) tears. Although rare these can cause loss of visual acuity. They can occur spontaneously in pigment epithelial detachment (PED) due to occult choroidal neovascularisation (CNV), retinal...
Intravitreal aflibercept for retinal angiomatous proliferation (RAP)
2 December 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this prospective study the authors present the visual and anatomical outcome of patients with RAP lesions who were treated with intravitreal aflibercept. The study cohort of 46 patients reached study completion at week 96. They were all Caucasians, with...
